C
China Regenerative Medicine International Ltd
HKEX:8592
China Regenerative Medicine International Ltd
HKEX:8592
Price:
0.98
HKD
Market Closed
Market Cap:
HK$279.7m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
C
|
China Regenerative Medicine International Ltd
HKEX:8592
|
HK |
|
Gemdale Properties and Investment Corporation Ltd
HKEX:535
|
HK |
|
Allied Farmers Ltd
NZX:ALF
|
NZ |
|
G
|
Greatech Technology Bhd
KLSE:GREATEC
|
MY |
|
P
|
Park Elektrik Uretim Madencilik Sanayi ve Ticaret AS
IST:PRKME.E
|
TR |
|
Yantai Tayho Advanced Materials Co Ltd
SZSE:002254
|
CN |
Relative Value
The Relative Value of one China Regenerative Medicine International Ltd stock under the Base Case scenario is hidden HKD. Compared to the current market price of 0.98 HKD, China Regenerative Medicine International Ltd is hidden .
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
China Regenerative Medicine International Ltd Relative Value
HIDDEN
Multiples Across Competitors
Competitors Multiples
China Regenerative Medicine International Ltd Competitors
China Regenerative Medicine International Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| HK |
C
|
China Regenerative Medicine International Ltd
HKEX:8592
|
89.8m HKD | 1.5 | 16.2 | 89.4 | 89.4 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 690 872.8 | -160 127.7 | -194 446.1 | -192 227.3 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
366.3B USD | 6 | 87.5 | 14.5 | 20.2 | |
| US |
|
Exact Sciences Corp
NASDAQ:EXAS
|
355.9B USD | 109.6 | -1 710.6 | 15 890.6 | -1 794.3 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
190.8B USD | 5.2 | 24.7 | 14.3 | 14.3 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
171.6B USD | 5.8 | 20.2 | 12.6 | 15.6 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
115.6B USD | 9.6 | 29.2 | 22 | 23 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 091 | -533.6 | -581 | -565.5 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
79.2B USD | 5.5 | 17.6 | 13 | 14.9 | |
| AU |
|
CSL Ltd
ASX:CSL
|
68B AUD | 3.2 | 35.2 | 11.6 | 14.6 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.1 | -61.8 | -66.6 | -60.1 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
